Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy

This case report describes a 67-year-old woman who had received adoptive immunotherapy with chimeric antigen receptor T cells for multiple myeloma and was experiencing parkinsonism-like symptoms.

Authors

Institutions

Publication Details

Journal
JAMA Neurology
Published
2024-08-12
DOI
https://doi.org/10.1001/jamaneurol.2024.2506
Citations
8
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
2.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy

Joachim M. Baehring, Jonas A. Gudera, Philipp Karschnia
8 citations
JAMA Neurology
CAR-T cell therapy research
2.26
article

Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy

Joachim M. Baehring, Jonas A. Gudera, Philipp Karschnia
article en
8 citations

Abstract

This case report describes a 67-year-old woman who had received adoptive immunotherapy with chimeric antigen receptor T cells for multiple myeloma and was experiencing parkinsonism-like symptoms.

JAMA NeurologyVol. 81(11)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Yale University (US), Ludwig-Maximilians-Universität München (DE)
Good health and well-being, Gender equality
Openalex Percentile: Top 10%
CAR-T cell therapy research
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.